Last edition
News about "VAI"
US FDA Inspection at Aurobindo Pharma Ltd's Unit XIV, Anakapalli District, Andhra Pradesh
US FDA Inspection at Aurobindo Pharma Ltd's Unit XIV, Anakapalli District, Andhra Pradesh
VAI | 18/07/2023 | By Sudeep Soparkar | 232
Lupin Receives EIR from U.S. FDA for its Pithampur Unit-2 Manufacturing Facility
Lupin Receives EIR from U.S. FDA for its Pithampur Unit-2 Manufacturing Facility
VAI | 13/07/2023 | By Sudeep Soparkar | 428
Bliss GVS Pharma Ltd updates on inspection by USFDA
Bliss GVS Pharma Ltd updates on inspection by USFDA
VAI | 16/06/2023 | By Sudeep Soparkar | 407
US FDA assigns VAI classification to Jubilant Pharmova's API facility at Nanjangud
This facility complies concerning current good manufacturing practices
VAI | 11/03/2023 | By Sudeep Soparkar | 320
Piramal Pharma's Lexington facility gets six observations from US FDA
The observations were classified under VAI (Voluntary Action Indicated) and do not relate to data integrity<br />
VAI | 17/01/2023 | By Sudeep Soparkar | 231
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy